CLINICAL AND ANTHROPOMETRIC CHARACTERISTICS OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND NON-ALCOHOLIC FATTY LIVER DISEASE

Authors

  • Kravchun N. A. SI "V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine", Kharkiv
  • Zemlyanitsyna O. V. SI "V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine", Kharkiv
  • Dorosh O. G. SI "V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine", Kharkiv https://orcid.org/0000-0003-4033-282X

DOI:

https://doi.org/10.21856/j-PEP.2012.1.04

Keywords:

type 2 diabetes mellitus, autoimmune thyroiditis, non-alcoholic fatty liver disease, clinical symptoms

Abstract

230 patients with type 2 diabetes mellitus were examined. In 83 (36,1 %) patients non-alcoholic fatty liver disease were diagnosed. In the patients examined dispeptic and astenovegetative syndromes as well as feelings of hardness, pressure under right ribs area, skin itching were found. Clinically significant distinctions between the symptoms in patients with diabetes mellitus and non-alcoholic fatty liver disease and in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease in combination with autoimmune thyroiditis were not found.

References

Prevalence of and risk factors for non-alcoholic fatty liver disease: the Dionysos Nutrition and Liver Study [Text] / G. Bedogni, L. Miglioli, F. Masutti [et al.] // Hepatology. — 2005. — Vol. 42. — P. 44–52.

Prevalence of hepatic steatosis in an urban population in the Unition States: impact of ethnicity. [Text] / J. D. Browning, L. S. Szczepaniac, R. Dobbins [et al.] // Hepatology. — 2004. — Vol. 40. — P. 1387–1395.

Clark, J. M. The prevalence and aetiology of elevated aminotransferase levels in the United States [Text] / J. M. Clark, F. L. Brancati, A. M. Diehl // Am. J. Gastroenterol. — 2003. — Vol. 98. — P. 960–967.

Ткач, С. М. Современные подходы к диагностике и лечению жировой болезни печени [Текст] / С. М. Ткач // Здоров’я України. — 2008. — № 22. — С. 64–65.

Оценка L-орнитин-L-аспартата (Гепа-Мерц) в комплексном лечении неалкогольного стеатогепатита [Текст] / М. Ф. Осипенко, А. В. Редькина, Е. А. Бикбулатова [и др.] // Гастроэнтерология. – 2010. – № 1. — С. 35–38.

Nonalcoholic fatty liver disease and the metabolic syndrome [Text] / G. Marchesini, R. Marzocchi, F. Agostini [et al.] //Curr. Opin. Lipidol. — 2005. — Vol. 16. — P. 421–427.

McCullough, A. J. Pathophysiology of non-alcoholic steato-heepatitis [Text] / A. J. McCullough // J. Clin. Gastroenterol. — 2006. — Vol. 40. — Suppl. 1 — S. 17–29.

Юрьев, К. Л. Силимарин: эффекты и механизмы действия, клиническая эффективность и безопасность [Текст] / К. Л. Юрьев // Укр. мед. часопис. — 2010. — № 3 (77). — С. 59–66.

Approach to the pathogenesis and treatment of nonalcoholic steatogepatitic [Text] / J. Medina, L. I. Fernandez-Salazar, L. Garcia-Buey [et al.] // Diabetes Care. — 2004. — Vol. 27. — P. 2057–2066.

Nonalcoholic fatty liver disease and risk future cardiovacsular events among type 2 diabetic patients [Text] / G. Targher, L. Bertolini, F. Poli [et al.] // Diabetes. — 2007. — Vol. 54. — P. 3541–3546.

Nonalcoholic fatty liver disease is independently assosiated with an increased incidence of cardiovascular events in type 2 diabetic patients [Text] / G. Targher, L. Bertolini, S. Rodella [et al.] // Diabetes Care. — 2007. — Vol. 30. — P. 2119–2121.

Celani, M. F. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus [Text] / M. F. Celani, M. E. Bonati, N. Stucci // Diabetes Res. — 1994. — Vol. 27 (1). — P. 15–25.

Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type [Text] / W. J. Irvine, C. J. McCallum, R. S. Gray [et al.] // Diabetes. — 1977. — Vol. 26. — P. 138–147.

Panz, V. R. Distribution of autoantibodies to glutamic acid decarboxylase across the spectrum of diabetes mellitus seen South Africa [Text] / V. R. Panz, W. J. Kalk, M. Zouvanis, B. I. Joffe // Diabet Med. — 2000. — Vol. 17 (7). — P. 524–527.

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes [Text] / R. Turner, I. Stratton, V. Horton [et al.] // Lancet. — 1997. — Vol. 350. — P. 1288–1293.

Ожирение [Текст] / Под ред. Н. А. Белякова и В. И. Мазурова. — СПб.: Изд. дом СПбМАПО, 2003. — 520 с.

Downloads

Published

2012-03-15

How to Cite

Kravchun, N. A., Zemlyanitsyna, O. V., & Dorosh, O. (2012). CLINICAL AND ANTHROPOMETRIC CHARACTERISTICS OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND NON-ALCOHOLIC FATTY LIVER DISEASE. Problems of Endocrine Pathology, 39(1), 33-37. https://doi.org/10.21856/j-PEP.2012.1.04

Issue

Section

CLINICAL ENDOCRINOLOGY

Most read articles by the same author(s)

1 2 3 4 5 6 > >>